DICE Therapeutics Study Site — New York, New York

DICE Therapeutics Study Site is a clinical research site located in New York, New York, United States 10003-3314.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

DICE Therapeutics Study Site has participated in 1 clinical trials.

Therapeutic areas: Plaque Psoriasis.

Sponsors: DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for DICE Therapeutics Study Site?

DICE Therapeutics Study Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has DICE Therapeutics Study Site conducted?

DICE Therapeutics Study Site has 1 clinical trials on record. Their work covers Plaque Psoriasis.

Is DICE Therapeutics Study Site accredited by Crixeo Health?

DICE Therapeutics Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about DICE Therapeutics Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.